2023
DOI: 10.1038/s41408-023-00828-4
|View full text |Cite
|
Sign up to set email alerts
|

E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 13 publications
0
0
0
Order By: Relevance
“…The interaction mediated by E-selectin offers potential therapeutic avenues for addressing various diseases. Various exogenous inhibitors, such as carbohydrate molecules, carbohydrate mimics, small and large molecular mass non-carbohydrate compounds, peptides, antibodies targeting selectins, or nanoparticles, have been explored in this pursuit ( 88 91 ). Here we summarizes notable advancements and approaches in the development of pharmaceutical agents targeting E-selectin.…”
Section: Therapeutic Approaches Targeting E-selectinmentioning
confidence: 99%
“…The interaction mediated by E-selectin offers potential therapeutic avenues for addressing various diseases. Various exogenous inhibitors, such as carbohydrate molecules, carbohydrate mimics, small and large molecular mass non-carbohydrate compounds, peptides, antibodies targeting selectins, or nanoparticles, have been explored in this pursuit ( 88 91 ). Here we summarizes notable advancements and approaches in the development of pharmaceutical agents targeting E-selectin.…”
Section: Therapeutic Approaches Targeting E-selectinmentioning
confidence: 99%